Dave
Honorary Master
- Joined
- Aug 31, 2008
- Messages
- 76,565
Not according to @Dave as he is in veterinary and the grant was in human vaccines
Or maybe you and the other nut are seriously suffering with confirmation bias? The grant was for a study involving MICE, I haven’t seen many mice described as human, when did you see them?
The grant is described by the Government of Ontario here.
Developing Prophylactic Virus-Vectored Vaccines for COVID-19 Byram Bridle, Leonardo Susta and Sarah Wootton (Co-Principal Investigators, University of Guelph); Darwyn Kobasa, National Microbiology Laboratory, Public Health Agency of Canada (Collaborator) University of Guelph
This research aims to develop a vaccination strategy for COVID-19. By developing avian avulavirus (AAvV-1) and adenovirus viral-vectored vaccines expressing the SARS-CoV-2 spike protein as a target antigen, researchers will test these vaccines in mice to identify a way to induce robust protective mucosal (respiratory, gastrointestinal and urogenital tract) and systemic immunity. Mucosal immunity plays a significant role in preventing pathogens from getting into the body. Systemic immunity clears any pathogens that bypass mucosal barriers. After optimization, these vaccines will be evaluated in a hamster challenge model at the National Microbiology Laboratory in Winnipeg.
